Lee's Pharmaceutical Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5438W1116
HKD
1.21
-0.3 (-19.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

403.0 k

Shareholding (Dec 2017)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 16.32%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 74.18

 
3

Positive results in Jun 25

4

With ROE of 14.79%, it has a Very Attractive valuation with a 0.65 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 866 Million ()

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

319.73%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

12.57%

stock-summary
Price to Book

0.45

Revenue and Profits:
Net Sales:
259 Million
(Quarterly Results - Dec 2017)
Net Profit:
47 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.97%
0%
-3.97%
6 Months
-1.63%
0%
-1.63%
1 Year
-0.82%
0%
-0.82%
2 Years
-16.55%
0%
-16.55%
3 Years
-36.32%
0%
-36.32%
4 Years
-74.79%
0%
-74.79%
5 Years
-69.67%
0%
-69.67%

Lee's Pharmaceutical Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.55%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
74.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.44
Tax Ratio
21.23%
Dividend Payout Ratio
28.46%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
26.07%
ROE (avg)
16.32%

Valuation key factors

Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.65
EV to EBIT
4.71
EV to EBITDA
4.43
EV to Capital Employed
0.65
EV to Sales
1.06
PEG Ratio
0.66
Dividend Yield
248.62%
ROCE (Latest)
13.72%
ROE (Latest)
14.79%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'17 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'17",
        "Dec'16",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "258.80",
          "val2": "231.20",
          "chgp": "11.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45.30",
          "val2": "72.40",
          "chgp": "-37.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.00",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.60",
          "val2": "-0.70",
          "chgp": "-128.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "47.20",
          "val2": "52.70",
          "chgp": "-10.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.90%",
          "val2": "313.30%",
          "chgp": "-13.84%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.95% vs -14.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 244.72% vs -56.55% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,400.00",
          "val2": "1,053.00",
          "chgp": "32.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "221.00",
          "val2": "109.80",
          "chgp": "101.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.20",
          "val2": "11.90",
          "chgp": "19.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-26.30",
          "val2": "-34.90",
          "chgp": "24.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "68.60",
          "val2": "19.90",
          "chgp": "244.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "52.30%",
          "val2": "-37.70%",
          "chgp": "9.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'17 - YoYstock-summary

Dec'17
Dec'16
Change(%)
Net Sales
258.80
231.20
11.94%
Operating Profit (PBDIT) excl Other Income
45.30
72.40
-37.43%
Interest
0.90
1.00
-10.00%
Exceptional Items
-1.60
-0.70
-128.57%
Consolidate Net Profit
47.20
52.70
-10.44%
Operating Profit Margin (Excl OI)
174.90%
313.30%
-13.84%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,400.00
1,053.00
32.95%
Operating Profit (PBDIT) excl Other Income
221.00
109.80
101.28%
Interest
14.20
11.90
19.33%
Exceptional Items
-26.30
-34.90
24.64%
Consolidate Net Profit
68.60
19.90
244.72%
Operating Profit Margin (Excl OI)
52.30%
-37.70%
9.00%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 32.95% vs -14.61% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 244.72% vs -56.55% in Dec 2023

stock-summaryCompany CV
About Lee's Pharmaceutical Holdings Ltd. stock-summary
stock-summary
Lee's Pharmaceutical Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available